Attempts have been made to obtain product information for the smartablate generator system used during this procedure, however, no additional information has been received.Since there is no product information, no product failure analysis can be conducted and no determination of possible contributing factors could be made.As such, the investigation will be closed.If additional information is received regarding clarification of the system used in this event, the complaint will be reopen and investigation will be performed and a supplemental 3500a report will be submitted to the fda.Manufacturing record evaluation cannot be conducted because no serial number is available.Concomitant medical products: carto® 3 system (us catalog # fg540000, serial # (b)(4)), pentaray d curve catheter (us catalog # unknown, lot # unknown), webster cs unidirectional f curve catheter(us catalog # unknown, lot # unknown).Manufacturer¿s ref # (b)(4).
|
It was reported that a patient underwent an atrial fibrillation (afib) ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter and a smartablate generator and suffered esophageal fistula.During the procedure, the patient suffered esophageal fistula.It is unknown if medical/surgical intervention was required.There¿s no information regarding extended hospitalization, patient¿s outcome or physician causality opinion.Multiple attempts have been made to gain clarification on this event with no response.Should any new information be obtained it will be assessed and processed accordingly.Biosense webster manufacturer's reference number (b)(4) has two reports related to the same event: mfr # 2029046-2019-02852 for product code unk_smartablate generator (smartablate generator).Mfr # 2029046-2019-02855 product code d134805 (thermocool® smart touch® sf bi-directional navigation catheter).
|
On 3/21/2019, confirmation was received from the biosense webster inc.Clinical account specialist, that it was discovered the patient did not have an atrial esophageal fistula.No patient consequences occurred from this procedure.However, since this event has already been reported to fda, biosense webster inc.Will continue to report supplemental mdrs to fda as additional information is received regarding this event.Patient code updated from 1862 (fistula) to 2199 (no consequences or impact to patient) device code updated from 2993 (adverse event without identified device or use problem) to 3189 (no apparent adverse event).Manufacturer¿s ref # (b)(4).
|